List of Tables
    Table 1. Granisetron Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Granisetron Market Trends
    Table 3. Granisetron Market Drivers
    Table 4. Granisetron Market Challenges
    Table 5. Granisetron Market Restraints
    Table 6. Global Granisetron Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Granisetron Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Granisetron Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Granisetron Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Granisetron Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Granisetron Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Granisetron Revenue Share by Player, 2017-2022
    Table 13. Global Granisetron Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Granisetron by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Granisetron as of 2021)
    Table 15. Top Players of Granisetron in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Granisetron Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Granisetron Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Granisetron Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Granisetron Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Granisetron Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Granisetron Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Granisetron Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Granisetron Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Granisetron Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Granisetron Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Granisetron Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Granisetron Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Granisetron Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Kyowa Kirin Company Details
    Table 31. Kyowa Kirin Business Overview
    Table 32. Kyowa Kirin Granisetron Product
    Table 33. Kyowa Kirin Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 34. Kyowa Kirin Recent Development
    Table 35. Heron Therapeutics Company Details
    Table 36. Heron Therapeutics Business Overview
    Table 37. Heron Therapeutics Granisetron Product
    Table 38. Heron Therapeutics Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 39. Heron Therapeutics Recent Development
    Table 40. Fresenius Kabi Company Details
    Table 41. Fresenius Kabi Business Overview
    Table 42. Fresenius Kabi Granisetron Product
    Table 43. Fresenius Kabi Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 44. Fresenius Kabi Recent Development
    Table 45. Hikma Pharmaceuticals Company Details
    Table 46. Hikma Pharmaceuticals Business Overview
    Table 47. Hikma Pharmaceuticals Granisetron Product
    Table 48. Hikma Pharmaceuticals Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 49. Hikma Pharmaceuticals Recent Development
    Table 50. Teva Company Details
    Table 51. Teva Business Overview
    Table 52. Teva Granisetron Product
    Table 53. Teva Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 54. Teva Recent Development
    Table 55. Cipla Company Details
    Table 56. Cipla Business Overview
    Table 57. Cipla Granisetron Product
    Table 58. Cipla Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 59. Cipla Recent Development
    Table 60. Sandoz Company Details
    Table 61. Sandoz Business Overview
    Table 62. Sandoz Granisetron Product
    Table 63. Sandoz Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 64. Sandoz Recent Development
    Table 65. Wockhardt Company Details
    Table 66. Wockhardt Business Overview
    Table 67. Wockhardt Granisetron Product
    Table 68. Wockhardt Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 69. Wockhardt Recent Development
    Table 70. Mylan Company Details
    Table 71. Mylan Business Overview
    Table 72. Mylan Granisetron Product
    Table 73. Mylan Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 74. Mylan Recent Development
    Table 75. APOTEX Company Details
    Table 76. APOTEX Business Overview
    Table 77. APOTEX Granisetron Product
    Table 78. APOTEX Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 79. APOTEX Recent Development
    Table 80. Dr.Reddy's Company Details
    Table 81. Dr.Reddy's Business Overview
    Table 82. Dr.Reddy's Granisetron Product
    Table 83. Dr.Reddy's Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 84. Dr.Reddy's Recent Development
    Table 85. Bluepharma Company Details
    Table 86. Bluepharma Business Overview
    Table 87. Bluepharma Granisetron Product
    Table 88. Bluepharma Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 89. Bluepharma Recent Development
    Table 90. Natco Pharma Company Details
    Table 91. Natco Pharma Business Overview
    Table 92. Natco Pharma Granisetron Product
    Table 93. Natco Pharma Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 94. Natco Pharma Recent Development
    Table 95. Akorn Company Details
    Table 96. Akorn Business Overview
    Table 97. Akorn Granisetron Product
    Table 98. Akorn Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 99. Akorn Recent Development
    Table 100. Taro Pharmaceutical Company Details
    Table 101. Taro Pharmaceutical Business Overview
    Table 102. Taro Pharmaceutical Granisetron Product
    Table 103. Taro Pharmaceutical Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 104. Taro Pharmaceutical Recent Development
    Table 105. Aurobindo Company Details
    Table 106. Aurobindo Business Overview
    Table 107. Aurobindo Granisetron Product
    Table 108. Aurobindo Revenue in Granisetron Business (2017-2022) & (US$ Million)
    Table 109. Aurobindo Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Granisetron Product Picture
    Figure 2. Global Granisetron Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Granisetron Market Size 2017-2028 (US$ Million)
    Figure 4. United States Granisetron Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Granisetron Market Size 2017-2028 (US$ Million)
    Figure 6. United States Granisetron Market Share in Global 2017-2028
    Figure 7. Granisetron Report Years Considered
    Figure 8. Product Picture of Transdermal system
    Figure 9. Product Picture of Injection
    Figure 10. Product Picture of Oral
    Figure 11. Global Granisetron Market Share by Type in 2022 & 2028
    Figure 12. Global Granisetron Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Granisetron Market Share by Type (2017-2028)
    Figure 14. United States Granisetron Market Share by Type in 2022 & 2028
    Figure 15. United States Granisetron Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Granisetron Market Share by Type (2017-2028)
    Figure 17. Product Picture of Chemotherapy
    Figure 18. Product Picture of Post operative
    Figure 19. Global Granisetron Market Share by Application in 2022 & 2028
    Figure 20. Global Granisetron Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Granisetron Market Share by Application (2017-2028)
    Figure 22. United States Granisetron Market Share by Application in 2022 & 2028
    Figure 23. United States Granisetron Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Granisetron Market Share by Application (2017-2028)
    Figure 25. North America Granisetron Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Granisetron Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Granisetron Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Granisetron Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Granisetron Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Granisetron Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Kyowa Kirin Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 54. Heron Therapeutics Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 55. Fresenius Kabi Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 56. Hikma Pharmaceuticals Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 57. Teva Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 58. Cipla Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 59. Sandoz Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 60. Wockhardt Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 61. Mylan Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 62. APOTEX Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 63. Dr.Reddy's Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 64. Bluepharma Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 65. Natco Pharma Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 66. Akorn Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 67. Taro Pharmaceutical Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 68. Aurobindo Revenue Growth Rate in Granisetron Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed